Compare GraniteShares 2x Long NVDA Daily ETF (NVDL) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long NVDA Daily ETF vs DENTSPLY SIRONA Inc — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $36.86 (market cap $3.56B), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: GraniteShares 2x Long NVDA Daily ETF is far larger — about 2.1× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long NVDA Daily ETF for 15 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| NVDL | XRAY | |
|---|---|---|
Market Cap | $3.56B | $1.73B |
Volume | 9,740,643 | 6,198,582 |
Sector | Leveraged / Inverse | Health |
52-Week High | $43.02 | $14.68 |
52-Week Low | $21.76 | $8.52 |
Typical Hold Time | 15 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $37.28, down 5.79% in the last session. Technical indicators show a bullish overall signal with moving averages supporting upside momentum while oscillators remain neutral. The ETF tracks Nvidia's performance with 2x daily leverage, benefiting from Nvidia's strong AI leadership and consistent earnings beats. Recent news highlights Nvidia's continued dominance in AI chips and the ETF's leveraged exposure to this growth story.
The outlook remains positive given Nvidia's AI market leadership and technical breakout potential, though leveraged ETF structure introduces volatility decay risks. Key support sits at $36 with resistance at $39-41. Investors should monitor Nvidia's earnings performance and broader AI sector trends for directional cues.
DENTSPLY SIRONA (XRAY) trades at $8.69, near its 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenue and negative net income margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The outlook remains challenging with persistent profitability issues and high debt levels, though analyst consensus suggests upside potential with a $13 price target. Key risks include margin pressure and competitive threats, requiring careful monitoring of the company's turnaround execution for any recovery signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
